Clinical Trials Details

A081105 ALCHEMIST- SUBSTUDY (Lung)

Randomized Study of Erlotinib VS Observation In Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

Clinical Trial Categories

  • Cancers and Other Neoplasms